Related Experiment Videos

[Toxicological studies on a new cephamycin, MT-141. X. Its perinatal and postnatal test in rats]

Insights

MT-141 demonstrated no adverse effects in pregnant and lactating rats, even at high doses. This perinatal and postnatal study found no impact on maternal health or offspring development, indicating safety.

Area of Science:

  • Pharmacology
  • Toxicology
  • Reproductive Science

Context:

  • Perinatal and postnatal studies are crucial for evaluating drug safety in vulnerable populations.
  • SD rats are a common model for assessing developmental and reproductive toxicity.

Purpose:

  • To evaluate the perinatal and postnatal effects of MT-141 in Sprague-Dawley (SD) rats.
  • To determine the maximal "no effective" dose of MT-141 in dams and their offspring.

Summary:

  • Dams were administered MT-141 (400, 800, 1,600 mg/kg/day) from gestation day 17 to postnatal day 21.
  • No significant adverse effects were observed on maternal body weight, food, or water intake.
  • MT-141 did not affect reproductive parameters, F1 offspring development, physiology, behavior, fertility, or cause fetal defects.

Impact:

  • Establishes a high maximal "no effective" dose for MT-141, exceeding 1,600 mg/kg/day.
  • Provides critical safety data for MT-141 during the perinatal and postnatal periods.
  • Supports the potential use of MT-141 with a favorable safety profile in reproductive contexts.

Related Concept Videos